Bioelectronics Corp (BIEL)

[GetSeriousOK]

Stanford Study appears to use ActiPatch, not RecoveryRx. Look under Design Details -- for Other Names, it says "ActiPatch."

https://clinicaltrials.gov/study/NCT05315297?id=NCT05315297&rank=1

Furthermore, they entered the Study Description in September 2022 and have not edited that since. I don't believe BIEL had any extra-strength RecoveryRx devices available in September 2022 so the study designers would have planned to use what was available at that time. And if they changed the device they SHOULD have updated that detail.

I doubt the Stanford people made mistakes on the clinicaltrials.gov page, but maybe they did. Regardless -- anyone claiming the Stanford Study is using the new extra-strength RecoveryRx should provide proof of that claim that's stronger than the proof I've provided here.